← Open Payments lookup

AMANDA PUCKETT: Open Payments

NPI 1114629037 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$607 in 19 payments from 5 companies in 2025. Trend: 2023 $940 · 2024 $399 · 2025 $607

Food & beverage: $607
CompanyPaymentsAmount
ABBVIE INC.7$267
Supernus Pharmaceuticals, Inc.8$235
Neurocrine BioSciences, Inc.2$49
Takeda Pharmaceuticals U.S.A., Inc.1$29
Otsuka America Pharmaceutical, Inc.1$28

Products named: VRAYLAR, Qelbree, INGREZZA, TRINTELLIX, ABILIFY MAINTENA.

Industry payments across MD — which companies pay providers there.